Ligand Pharmaceuticals
LGND
LGND
251 hedge funds and large institutions have $2.19B invested in Ligand Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 89 increasing their positions, 97 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 39
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
89% less call options, than puts
Call options by funds: $12.7M | Put options by funds: $120M
Holders
251
Holding in Top 10
3
Calls
$12.7M
Puts
$120M
Top Buyers
| 1 | +$39M | |
| 2 | +$21.8M | |
| 3 | +$20.7M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$18.8M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$13.6M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$15.2M | |
| 3 | -$11.4M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$9.84M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$9.41M |